跳至主要内容
临床试验/NCT06828458
NCT06828458尚未招募不适用

Determining Elements of Anti-Fungal Immunity in BURN Patients

Assistance Publique - Hôpitaux de Paris0 个研究点目标入组 327 人开始时间: 2025年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
327
主要终点
Invasive fungal disease (IFD) onset during hospitalisation time

研究概览

简要总结

Scientific justification Invasive fungal diseases (IFDs) pose a substantial threat, especially in immunocompromised patients, necessitating urgent research focus and therapeutic advancements. The IFI-BURN study, involving a cohort of patients with severe burn injury (n=276), revealed a significant IFD incidence of 31.6% and underscored their critical impact on morbidity and mortality. While fungi are present everywhere, for moulds within the environment and for yeasts within our microbiota, why certain patients develop IFDs and others do not, remains poorly understood. The answer most likely resides in the impact of the burn injury on the immune response, loss of skin barrier and particular predisposing immune phenotype of patients. The immune system is composed of both cellular and humoral components, but the latter is far less studied in antifungal immunity although they exert multiple antimicrobial mechanisms.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Burn patients
  • Adult patients ≥ 18 years old
  • Admission < 4 days following burn injury
  • Total burn surface Area ≥ 15%
  • Non opposition of the patient or his/her relatives to the research
  • Affiliation to social security or any health insurance

排除标准

  • Pregnancy
  • Opposition of the patient or his/her relatives
  • Decision not to resuscitate or to limit or stop active therapies

结局指标

主要结局

Invasive fungal disease (IFD) onset during hospitalisation time

时间窗: Up to 18 months

Proven IFD according to EORTC/MSGERC criteria applicable for invasive candidiasis. Putative invasive mold infection is defined with ≥ 2 positive culture from skin biopsy/bronchoalveolar lavage or ≥ 2 positive blood specific qPCR (aspergilosis, mucorales, fusariosis) or a combination of both. Possible invasive mold infection is defined with only one positive mycological criterion.

次要结局

  • Hospital mortality(Up to 18 months)
  • Overall survival(At day 90)
  • Incidence of organ failure during hospitalisation(Up to 18 months)
  • Severity score at admission(At inclusion)
  • Number of days without renal replacement therapy(At day 30)
  • Length of stay in hospital(Up to 18 months)
  • Number of days without mechanical ventilation(At day 30)
  • Length of stay in Intensive Care Unit(Up to 18 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验